Literature DB >> 533227

Use of sodium salicylate as a blocking agent for cortisol-binding-globulin in a radioimmunoassay for cortisol on unextracted plasma.

J W Kane.   

Abstract

This report describes investigations into the use of sodium salicylate as a cortisol-binding-globulin blocking agent and the subsequent development of a radioimmunoassay for cortisol on unextracted plasma. Cortisol antiserum was raised against a cortisol 3-O-(carboxy-methyl) oxime-bovine serum albumin conjugate. A 125I-labelled cortisol-tyrosine methyl ester conjugate was also prepared for use in the assay. The radioimmunoassay developed involved no pre-treatment of extraction of the samples before analysis and was extremely simple to perform. Comparison with another radioimmunoassay for cortisol and with the Mattingly fluorimetric assay gave good correlation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533227     DOI: 10.1177/000456327901600149

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  Tinnitus and hyperacusis: Contributions of paraflocculus, reticular formation and stress.

Authors:  Yu-Chen Chen; Guang-Di Chen; Benjamin D Auerbach; Senthilvelan Manohar; Kelly Radziwon; Richard Salvi
Journal:  Hear Res       Date:  2017-03-07       Impact factor: 3.208

2.  Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects?

Authors:  T Richardson; J Foster; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

3.  Treatment of Cushing's disease with low dose radiation therapy.

Authors:  S R Ahmed; S M Shalet; C G Beardwell; M L Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

4.  Trilostane in the treatment of advanced breast cancer.

Authors:  C G Beardwell; A C Hindley; P M Wilkinson; I D Todd; G G Ribeiro; D Bu'Lock
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.